COMMUNIQUÉS West-GlobeNewswire

ChemoCentryx to Present at Two Upcoming Investor Conferences

30/05/2018 - 14:30

MOUNTAIN VIEW, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]

Interpace Diagnostics Enters into Agreement with Nationally Renowned Institution

30/05/2018 - 14:30

Agreement Covers Both of the Company’s Molecular Thyroid Tests PARSIPPANY, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial [...]

Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement

30/05/2018 - 14:30

Sunnyvale, CA , May 30, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company has achieved the clinical testing accuracy required for [...]

Avinger Announces Presentations and Posters Featuring Lumivascular Technology at New Cardiovascular Horizons Annual Conference

30/05/2018 - 14:30

REDWOOD CITY, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of sessions and posters [...]

Agritek Holdings Inc. Receives Hemp Licensee Approval Of American Hemp Trading Company For Company's Colorado Eighty Acre Hemp Production Farm In Pueblo, Colorado

30/05/2018 - 14:30

LOS ANGELES, CA, May 30, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

Minerva Neurosciences to Present at Jefferies 2018 Global Healthcare Conference on June 6, 2018

30/05/2018 - 14:30

WALTHAM, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system [...]

APEIRON to Present Clinical Data on Two Immunotherapy Programs at the 2018 ASCO Annual Meeting

30/05/2018 - 14:27

VIENNA, Austria, May 30, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today announced it would present data on two of its key programs in three poster presentations at the [...]

Tabula Rasa HealthCare Announces Two New Members to the Executive Team

30/05/2018 - 14:25

Kim Browning, CHC, PMP, Named EVP; Alan D. Stein, MD, PhD, SVP Healthcare Analytics MOORESTOWN, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC ), a healthcare technology [...]

PositiveID Mid-Year Update: Company Advances FireflyDX Testing and Partnership Discussions, and Expands Caregiver Market Penetration

30/05/2018 - 14:05

DELRAY BEACH, Fla., May 30, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, is proud to provide stockholders with [...]

AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer

30/05/2018 - 14:03

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Intra-Cellular Therapies to Present at the Jefferies 2018 Global Healthcare Conference

30/05/2018 - 14:00

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]

Positive New Data from Ongoing TACTI-mel Study in Unresectable or Metastatic Melanoma Presented in Global Webcast

30/05/2018 - 14:00

New data presented shows ORR of 61% (11/18 patients) SYDNEY, Australia, May 30, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) ("Immutep“ or “the Company“), a biotechnology company developing novel [...]

Immunomedics to Present at Jefferies 2018 Global Healthcare Conference

30/05/2018 - 14:00

MORRIS PLAINS, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”), a science-based and innovation-focused biopharmaceutical company committed to the development [...]

TRACON Pharmaceuticals Appoints Biotech Industry Veteran Mark Wiggins as Chief Business Officer

30/05/2018 - 14:00

Mr. Wiggins Brings Over 30 Years of Business Development and Commercial Experience in Biotech to TRACON SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a biopharmaceutical company [...]

Tonix Pharmaceuticals to Present at the 2018 BIO International Convention

30/05/2018 - 14:00

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present an overview [...]

Allena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference

30/05/2018 - 14:00

NEWTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ), a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme [...]

Humanigen CEO to Present at 8th Annual LD Micro Invitational

30/05/2018 - 14:00

BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company developing cutting-edge T-cell optimization and oncology treatments, today announced that Cameron Durrant, M [...]

Ovid Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference on June 8, 2018

30/05/2018 - 14:00

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

BioSyent Releases Results for Q1 2018

30/05/2018 - 14:00

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three months ended March 31, 2018. Key highlights include: First quarter ( [...]